| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS INC | 12,850,000 | 106,270,000 | 24.45% | ||
| 2 | ABBVIE INC | 1,580,000 | 106,160,000 | 24.43% | ||
| 3 | QUEST DIAGNOSTICS INC | 575,000 | 41,699,000 | 9.60% | ||
| 4 | MEDICINES CO | 1,361,900 | 38,964,000 | 8.97% | ||
| 5 | AEGERION PHARMACEUTICALS INC | 2,036,829 | 38,639,000 | 8.89% | ||
| 6 | AMGEN INC | 200,000 | 30,704,000 | 7.07% | ||
| 7 | MERCK & CO INC | 400,000 | 22,772,000 | 5.24% | ||
| 8 | INTRA CELLULAR THERAPIES INC COM | 360,000 | 11,502,000 | 2.65% | ||
| 9 | Apricus Biosciences, Inc. | 6,524,505 | 11,157,000 | 2.57% | ||
| 10 | REPROS THERAPEUTICS INC | 1,132,367 | 8,096,000 | 1.86% | ||
| 11 | VIVUS INC | 2,573,943 | 6,075,000 | 1.40% | ||
| 12 | KINDRED BIOSCIENCES INC | 689,091 | 4,700,000 | 1.08% | ||
| 13 | AVEO PHARMACEUTICALS INC | 2,313,759 | 4,026,000 | 0.93% | ||
| 14 | ANI PHARMACEUTICALS INC COM | 31,000 | 1,924,000 | 0.44% | ||
| 15 | TARGACEPT INC | 630,000 | 1,758,000 | 0.40% | ||
| 16 | ELEVEN BIOTHERAPEUTICS INC | 41,200 | 116,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-15-032371, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
